France· FR:63316225
ORPHACOL 50 mg, gélule
A medicinal product containing acide cholique, registered in France by THERAVIA.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ACIDE CHOLIQUE
- Manufacturer
- THERAVIA
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009416886073 plaquette(s) PVC-Aluminium de 10 gélule(s)
- cip1334009416887756 plaquette(s) PVC-Aluminium de 10 gélule(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acide cholique in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaORPHACOLTHERAVIA, Neuilly-sur-Seine
- United KingdomKolbam 50mg capsulesRetrophin Inc
- FinlandKolbamRetrophin Europe Limited
- BelgiumKolbam 50 mgASK Pharmaceuticals
- NetherlandsOrphacol 50 mg, harde capsulesLaboratoires CTRS
- PolandOrphacolTHERAVIA
- SwedenOrphacol 50 mg Kapsel, hårdTheravia
- United StatesCHOLBAMMirum Pharmaceuticals Inc.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Orphacol
- Iceland · Orphacol
- Liechtenstein · Orphacol
- Norway · Orphacol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/52f4e491-b8ea-4b1f-8f62-3ec4da640f61 GET /v1/drugs/52f4e491-b8ea-4b1f-8f62-3ec4da640f61?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63316225",
"date_amm": "2013-09-12",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/13/870",
"substance": "ACIDE CHOLIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about acide cholique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.